The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance

In vitro and in vivo resistance to prednisolone are predictive for an adverse prognosis in pediatric precursor B-acute lymphoblastic leukemia. Causes of resistance are still poorly understood. In this study, we observed that prednisolone exposure of prednisolone-sensitive patients’ leukemic cells decreased anti-apoptotic MCL1 protein levels by 2.9-fold, while MCL1 protein expression in prednisolone-resistant leukemic patients’ cells was unaffected (P<0.01). Locked nucleic acid oligonucleotides directed against MCL1 reduced MCL1 protein levels by 82±16% (P<0.05) in leukemic cells, decreased proliferation by 9-fold and sensitized to prednisolone up to 80.8-fold, compared to a non-silencing-control locked nucleic acid (P<0.05). Remarkably, we discovered that MCL1-silencing up-regulated the glucose consumption of leukemic cells by 2.5-fold (P<0.05), suggesting a potential rescue mechanism mediated by glycolysis. Targeting glycolysis by 2-deoxyglucose synergistically inhibited leukemic survival by 23.2-fold in MCL1-silenced cells (P<0.05). Moreover, 2-deoxyglucose and MCL1 locked nucleic acid concomitantly sensitized leukemic cells to prednisolone compared to MCL1 locked nucleic acid or 2-deoxyglucose alone (P<0.05). In conclusion, these results indicate the need to target both MCL1 and glycolysis simultaneously to inhibit leukemic survival and sensitize acute leukemia patients towards prednisolone.

[1]  R. Stam,et al.  Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia , 2012, Leukemia.

[2]  Daniel P. Stewart,et al.  Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration , 2012, Nature Cell Biology.

[3]  S. Stone-Elander,et al.  Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells , 2011, Blood cancer journal.

[4]  D. Campana,et al.  Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. , 2011, Blood.

[5]  J. Rathmell,et al.  Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl. , 2010, Cancer research.

[6]  I. Ben-Sahra,et al.  The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells , 2010, Autophagy.

[7]  John Calvin Reed,et al.  A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy , 2010, Cell Death and Disease.

[8]  B. Schäfer,et al.  Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. , 2010, The Journal of clinical investigation.

[9]  P. Auberger,et al.  Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation , 2010, Oncogene.

[10]  S. Armstrong,et al.  Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. , 2010, Blood.

[11]  R. Aft,et al.  Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells. , 2009, Journal of cancer research and therapeutics.

[12]  M. Hogarty,et al.  Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists , 2009, Cancer biology & therapy.

[13]  P. Oefner,et al.  Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis , 2009, Leukemia.

[14]  Yan Luo,et al.  Adenosine-containing molecules amplify glucose signaling and enhance txnip expression. , 2009, Molecular endocrinology.

[15]  W. Evans,et al.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. , 2009, Blood.

[16]  B. Antonsson,et al.  Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems. , 2008, Biochemical pharmacology.

[17]  S. Kauppinen,et al.  Chapter 5:Locked Nucleic Acid: Properties and Therapeutic Aspects , 2008 .

[18]  Laurent Bélec,et al.  Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis , 2007, Proceedings of the National Academy of Sciences.

[19]  B. Zhivotovsky,et al.  Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members , 2007, Haematologica.

[20]  S. Pervaiz,et al.  Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells , 2007, Cell Death and Differentiation.

[21]  T. Golub,et al.  Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.

[22]  Martin J Firth,et al.  Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia , 2006, Leukemia.

[23]  C. Distelhorst,et al.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis , 2006, Oncogene.

[24]  S. Armstrong,et al.  Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. , 2005, Blood.

[25]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[26]  E. Wickstrom,et al.  Inhibition of Glucocorticoid-induced Apoptosis by Targeting the Major Splice Variants of BIM mRNA with Small Interfering RNA and Short Hairpin RNA* , 2004, Journal of Biological Chemistry.

[27]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[28]  M. D. Boer,et al.  Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. R. Datta,et al.  BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis , 2003, Nature.

[30]  M. V. Heiden,et al.  Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. , 1999, Molecular cell.

[31]  R. Pieters,et al.  Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. , 1998, Blood.

[32]  A. Berns,et al.  T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage‐induced cell death in the absence of p53. , 1996, The EMBO journal.

[33]  R. Pieters,et al.  In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. , 1995, Blood.

[34]  É. Hajduch,et al.  Regulation of glucose transporters in cultured rat adipocytes: synergistic effect of insulin and dexamethasone on GLUT4 gene expression through promoter activation. , 1995, Endocrinology.

[35]  M C Berenbaum,et al.  Synergy, additivism and antagonism in immunosuppression. A critical review. , 1977, Clinical and experimental immunology.

[36]  J. Seckl,et al.  Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells. , 2011, Leukemia research.

[37]  I. Ben-Sahra,et al.  The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells. , 2010, Autophagy.

[38]  O. Ilkayeva,et al.  Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. , 2007, Molecular and cellular biology.

[39]  Glycogen Synthase Kinase 3 (cid:2) and 3 (cid:3) Mediate a Glucose-Sensitive Antiapoptotic Signaling Pathway To Stabilize Mcl-1 (cid:1) , 2022 .